Observational study: Revascularization practices and outcomes in patients with multivessel coronary artery disease who presented with acute myocardial infarction and cardiogenic shock

Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018 – JAMA Internal Medicine (free for a limited period)

Editorial: Multivessel or Culprit Vessel–Only Percutaneous Coronary Intervention for Patients With Acute Myocardial Infarction and Cardiogenic Shock: Real-World Evidence in Support of CULPRIT-SHOCK (free for a limited period)

Commentaries: Multivessel PCI Associated With Higher In-Hospital Mortality Compared With Culprit-Vessel PCI, NCDR Study Finds – American College of Cardiology AND Less aggressive treatment better for heart patients who go into shock – Yale University

Related Research: PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock – New England Journal of Medicine AND One-Year Outcomes after PCI Strategies in Cardiogenic Shock – New England Journal of Medicine

Commentary on Twitter (Thread – Click for more)

In @JAMAInternalMed is our evaluation of revascularization practices in AMI w shock

In 2017, CULPRIT-SHOCK found harm w MV-PCI in MV-CAD – in the decade preceding it, MV-PCI was an increasingly popular strategy.

?below

w/ @rwyeh @ACCinTouch https://t.co/xz0HHnvhNU pic.twitter.com/DWaVXG8vcU

— Rohan Khera (@rohan_khera) August 24, 2020